Codiak BioSciences' GAAP loss for six months of 2021 was $32.117 million, down 16.4% from $38.415 million in the previous year. Revenue increased 43-fold to $14.081 million from $0.321 million a year earlier.
Codiak BioSciences' GAAP loss for six months of 2021 was $32.117 million, down 16.4% from $38.415 million in the previous year. Revenue increased 43-fold to $14.081 million from $0.321 million a year earlier. 
ir.codiakbio.com
English (US) 